Aveo shares drop with uncertainty of NDA submission for Fotivda

By Sandi Wong | Jan 31, 2019 | 7:23 PM GMT

Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) lost $1.07 (60%) to $0.70 Thursday after the company said it will not submit an NDA to FDA